Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dare Bioscience Inc
(NQ:
DARE
)
3.500
-0.700 (-16.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dare Bioscience Inc
< Previous
1
2
3
4
Next >
DARE Stock Earnings: Dare Bioscience Beats Revenue for Q2 2024
August 12, 2024
DARE stock results show that Dare Bioscience beat on revenue for the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
May 30, 2024
Via
Benzinga
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 21, 2024
Via
Benzinga
Recap: Dare Bioscience Q4 Earnings
March 28, 2024
Via
Benzinga
Dare Bioscience Earnings Preview
March 27, 2024
Via
Benzinga
Earnings Outlook For Dare Bioscience
November 08, 2023
Via
Benzinga
Earnings Outlook For Dare Bioscience
August 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 21, 2024
Via
Benzinga
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
May 17, 2024
Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.
Via
Benzinga
DARE Stock Earnings: Dare Bioscience Misses EPS, Beats Revenue for Q1 2024
May 14, 2024
DARE stock results show that Dare Bioscience missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 25, 2024
Via
Benzinga
Recap: Dare Bioscience Q1 Earnings
May 11, 2023
Via
Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 28, 2024
Via
Benzinga
DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023
March 28, 2024
DARE stock results show that Dare Bioscience beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
February 21, 2024
Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 01, 2024
It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!
Via
InvestorPlace
Earnings Scheduled For March 28, 2024
March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via
Benzinga
Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation
December 20, 2023
Daré Bioscience Inc (NASDAQ: DARE) announced topline results from the Phase 1 DARE-PDM1-001 study evaluating the pharmacokinetics (PK), safety, and exploratory efficacy of DARE-PDM1 an investigational...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 20, 2023
Via
Benzinga
FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
December 07, 2023
Daré Bioscience Inc (NASDAQ: DARE) announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option for moderate to severe dyspareunia,...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 20, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
July 31, 2023
On Monday, 27 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
July 21, 2023
On Friday, 54 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
July 17, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.